Infectious Diseases News

As of Feb. 1, there have been at least 24 million illnesses, 310,000 hospitalizations and 13,000 deaths across the United States related to influenza during the 2024-2025 season, according to the CDC.

A measles outbreak in Texas has climbed to nearly 60 cases in 3 weeks, with most cases occurring among unvaccinated children, according to state health officials.

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV infection and set a date of June 19 to decide on its approval, Gilead announced Tuesday.

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against five meningococcal serogroups, the company announced.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ease dengue virus symptoms when given before and after infection.

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study.

CDC data show that seasonal influenza activity is significantly elevated across the United States, and that influenza activity is at its highest level in more than 15 years.

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and determining their health care-associated transmission, researchers found.

Last week the CDC published Morbidity and Mortality Weekly Report for the first time since the Trump administration froze public communications from various national health agencies.